551 related articles for article (PubMed ID: 30880405)
21. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
22. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
[TBL] [Abstract][Full Text] [Related]
23. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
[TBL] [Abstract][Full Text] [Related]
24. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Kircanski K; Williams LM; Gotlib IH
Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
[TBL] [Abstract][Full Text] [Related]
25. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
Nelson JC; Delucchi K; Schneider LS
Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
[TBL] [Abstract][Full Text] [Related]
26. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
Bandelow B; Bauer M; Vieta E; El-Khalili N; Gustafsson U; Earley WR; Eriksson H
World J Biol Psychiatry; 2014 Feb; 15(2):155-66. PubMed ID: 24506289
[TBL] [Abstract][Full Text] [Related]
27. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
[TBL] [Abstract][Full Text] [Related]
28. Does comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study).
Seo HJ; Song HR; Jeong S; Kim JB; Lee MS; Kim JM; Yim HW; Jun TY
J Affect Disord; 2014 Jan; 152-154():352-9. PubMed ID: 24144584
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial.
Heo JY; Jeon HJ; Fava M; Mischoulon D; Baer L; Clain A; Doorley J; Pisoni A; Papakostas GI
J Psychiatr Res; 2015 Mar; 62():56-61. PubMed ID: 25659187
[TBL] [Abstract][Full Text] [Related]
30. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
[TBL] [Abstract][Full Text] [Related]
31. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
33. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
34. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
35. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR
Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937
[TBL] [Abstract][Full Text] [Related]
36. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension.
Fava M; Rush AJ; Alpert JE; Carmin CN; Balasubramani GK; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K
Can J Psychiatry; 2006 Nov; 51(13):823-35. PubMed ID: 17195602
[TBL] [Abstract][Full Text] [Related]
37. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
[TBL] [Abstract][Full Text] [Related]
38. Clinical differences between early and late remission in depressive patients.
Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
[TBL] [Abstract][Full Text] [Related]
39. Residual anxiety symptoms in depressed primary care patients.
McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.
Jha MK; South C; Trivedi J; Minhajuddin A; Rush AJ; Trivedi MH
Int J Neuropsychopharmacol; 2019 May; 22(5):339-348. PubMed ID: 30958879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]